🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immunotherapy with agents stimulating the immune system to act against canc...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2020-02-24
Trial ID
NCT04146064
Treatments Being Tested
The study is to explore the efficacy and safety of SCT200 with SCT-I10A or ...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2022-06-15
Trial ID
NCT05552807
Treatments Being Tested
The study is a prospective, randomized controlled phase III trial aimed to ...
Status
Completed
Location
Central Alabama Research
Start Date
2016-12
Trial ID
NCT02973789
Treatments Being Tested
The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Status
Not Yet Recruiting
Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-02-15
Trial ID
NCT07317778
The CR1STAL-Adaptive study is a randomized, open-label, phase II multicente...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2026-03-10
Trial ID
NCT06951646
Treatments Being Tested
This phase III trial compares standard therapy given after surgery (adjuvan...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-12-11
Trial ID
NCT06632327
The study is divided into two cohorts (Cohort 1 and Cohort 2), to which par...
Status
Recruiting
Location
Yale University School of Medicine
Start Date
2025-06-10
Trial ID
NCT06340568
Treatments Being Tested
This study is a single-arm Phase II trial designed to evaluate the efficacy...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-01-01
Trial ID
NCT07354984
Treatments Being Tested
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
This is a multicenter Phase 1b, open-label study to assess safety, tolerabi...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #53
Start Date
2017-09-05
Trial ID
NCT03170960
Treatments Being Tested